Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TDGF1 anticorps (Internal Region)

TDGF1 Reactivité: Humain, Souris WB, EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN401391
  • Antigène Voir toutes TDGF1 Anticorps
    TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
    Épitope
    • 15
    • 6
    • 6
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reactivité
    • 60
    • 18
    • 8
    Humain, Souris
    Hôte
    • 42
    • 19
    • 2
    • 1
    Lapin
    Clonalité
    • 43
    • 20
    Polyclonal
    Conjugué
    • 22
    • 6
    • 6
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TDGF1 est non-conjugé
    Application
    • 34
    • 32
    • 24
    • 13
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Specificité
    This antibody is specific for Cripto-1 protein. Expect cross-reactivity with Cripto-3 (TDGF2) based on very high levels of sequence conservation.
    Réactivité croisée (Details)
    Species reactivity (expected):Mouse.
    Species reactivity (tested):Human.
    Purification
    Affinity chromatography
    Immunogène
    Synthetic peptide corresponding to an internal sequence of human Cripto-1 protein
    Isotype
    IgG
    Top Product
    Discover our top product TDGF1 Anticorps primaire
  • Indications d'application
    ELISA: 1/50,000 - 1/150,000. Western Blot: 1/500 - 1/2,000.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    0.80 mg/mL (by UV absorbance at 280 nm)
    Buffer
    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 containing 0.01 % (w/v) Sodium Azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    -20 °C
  • Antigène
    TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
    Autre désignation
    TDGF1 / CRIPTO (TDGF1 Produits)
    Synonymes
    anticorps CR, anticorps CRGF, anticorps CRIPTO, anticorps CR1, anticorps cripto, anticorps cb85, anticorps tdgf1, anticorps wu:fe01d04, anticorps zgc:109829, anticorps Cripto-1, anticorps cr1, anticorps cr1a, anticorps frl-1, anticorps frl1, anticorps xcr1, anticorps TDGF1, anticorps tdgf3, anticorps cripto-3, anticorps teratocarcinoma-derived growth factor 1, anticorps teratocarcinoma-derived growth factor 1, member 3 L homeolog, anticorps teratocarcinoma-derived growth factor 1, member 1, anticorps TDGF1, anticorps Tdgf1, anticorps tdgf1, anticorps tdgf1.3.L, anticorps tdgf1.1
    Sujet
    Human Cripto-1 (CR-1), also known as Teratocarcinoma-derived growth factor 1 (TDGF1), is a member of the epidermal growth factor (EGF)-GFC family and has been implicated in both embryogenesis and carcinogenesis. During early vertebrate development, CR-1 functions as a co-receptor for Nodal, a transforming growth factor beta (TGFbeta) family member, and is essential for mesoderm and endoderm formation and anterior-posterior and left-right axis establishment. In adult tissues, CR-1 is expressed at a low level in all stages of mammary gland development, and expression increases during pregnancy and lactation. Over-expression of CR-1 in mouse mammary epithelial cells leads to their transformation in vitro, and when injected in mammary glands, CR-1 produces ductal hyperplasias.Synonyms: CRGF, Cripto-1 growth factor, Epidermal growth factor-like cripto protein CR1, Teratocarcinoma-derived growth factor 1
    ID gène
    6997
    NCBI Accession
    NP_001167607
    UniProt
    P13385
    Pathways
    EGFR Signaling Pathway
Vous êtes ici:
Support technique